QCDR Status Approved for GIQuIC Registry in 2024

QCDR: Qualified Clinical Data Registry for MIPS

We are pleased to announce that the GIQuIC Registry has once again been approved as a Qualified Clinical Data Registry (QCDR) for reporting to the Merit‐based Incentive Payment System (MIPS) for the 2024 reporting year.

The QCDR reporting mechanism is a dynamic reporting option that allows providers to report on Quality Payment Program and QCDR measures that are meaningful to their specialty practice and foster improvement in the quality of care provided to patients.

The 2024 GIQuIC QCDR is approved to report for individual eligible providers, groups, and virtual groups to the Quality, Promoting Interoperability, and Improvement Activities performance categories.

QCDR Information & Resources

  • Webinar: GIQuIC will host an informational webinar on reporting via the GIQuIC 2024 QCDR in Spring 2024.  

  • Measures: See the list of measures available for reporting to the MIPS Quality performance category via the GIQuIC 2024 QCDR.
  • IMPORTANT NOTE: A provider or group must be registered and submitting data to the GIQuIC registry no later than June 30, 2024 to be eligible to report to MIPS via the GIQuIC QCDR for the 2024 reporting year.
  • GIQuIC questions: For more information, visit the GIQuIC registry website or email info@giquic.org.
  • Medicare Quality Payment Program (QPP): Visit the CMS website.

New Year, New Registry Platform!

Effective January 1, 2024, GIQuIC is partnering with Health Catalyst to provide a next-generation registry platform. In addition to streamlining data collection, this collaboration will allow for the expansion of the registry to include additional endoscopic procedures and disease states to support delivery of high-quality care for all digestive disease patients.

Thank you for your time. Please contact your member organization with any questions:

American Society for Gastrointestinal Endoscopy
(630) 573-0600

(240) 437-3400

American College of Gastroenterology
(301) 263-9000

About Gastrointestinal Endoscopy
Gastrointestinal endoscopic procedures allow the gastroenterologist to visually inspect the upper gastrointestinal tract (esophagus, stomach and duodenum) and the lower bowel (colon and rectum) through an endoscope, a thin, flexible device with a lighted end and a powerful lens system. Endoscopy has been a major advance in the treatment of gastrointestinal diseases. For example, the use of endoscopes allows the detection of ulcers, cancers, polyps and sites of internal bleeding. Through endoscopy, tissue samples (biopsies) may be obtained, areas of blockage can be opened and active bleeding can be stopped. Polyps in the colon can be removed, which has been shown to prevent colon cancer.

About the American Society for Gastrointestinal Endoscopy
Since its founding in 1941, the American Society for Gastrointestinal Endoscopy (ASGE) has been dedicated to advancing patient care and digestive health by promoting excellence and innovation in gastrointestinal endoscopy. ASGE, with almost 16,000 members worldwide, promotes the highest standards for endoscopic training and practice, fosters endoscopic research, recognizes distinguished contributions to endoscopy, and is the foremost resource for endoscopic education. Visit Asge.org and ValueOfColonoscopy.org for more information and to find a qualified doctor in your area.


American Society for Gastrointestinal Endoscopy
3300 Woodcreek Drive Downers Grove, IL 60515
P (630) 573-0600
F (630) 963-8332

Media Contact

Andrea Lee
Director of Marketing and Communications